Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Capital/Financing Update 2011

Sep 27, 2011

1643_rns_2011-09-27_eb2fa216-2986-4607-9320-9e46be941fbe.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

FWP 1 d237062dfwp.htm FWP FWP

Filed pursuant to Rule 433

Registration Statement No. 333-165472

September 27, 2011

Final Term Sheet

Sanofi

Final Term Sheet

$1,000,000,000 1.200% Notes Due 2014

Issuer Sanofi
Format SEC-registered global notes
Title 1.200% Notes due 2014
Total initial principal amount being issued $1,000,000,000
Issue price 99.877%
Pricing date September 27, 2011
Expected settlement date September 30, 2011
Please note that the preliminary prospectus supplement to which this termsheet relates indicates that settlement might occur on the fifth business day following the date of the pricing of the
Notes. It has been decided that settlement will occur on the third business day following the date of the pricing of the Notes, i.e., September 30, 2011.
Maturity date September 30, 2014, unless earlier redeemed
Day count 30/360
Day count convention Following unadjusted
Optional redemption Make-whole call at Treasury Rate plus 15 bps
Tax redemption Applicable
Ranking Unsecured and unsubordinated
Interest rate 1.200% per annum
Benchmark Treasury 0.250% due September 15, 2014
Benchmark Treasury price 99-16 3 / 4
Benchmark Treasury yield 0.412%
Spread to Benchmark Treasury 83 bps
Yield to maturity 1.242%
Date interest starts accruing September 30, 2011
Interest payment dates Each March 30 and September 30
First interest payment date March 30, 2012
Regular record dates for Interest Each March 15 and September 15
Trustee Deutsche Bank Trust Company Americas
Listing None
Denominations $2,000 and increments of $1,000
Expected ratings of the Notes Moody’s: A2/Stable
Standard & Poor’s: AA-/Stable
Note: A security rating is not a recommendation to buy, sell or hold securities. Ratings are subject to revision or withdrawal at any time by the assigning rating organization. Each rating
should be evaluated independently of any other rating.
CUSIP / ISIN 801060AA2 / US801060AA22
Joint Book-Running Managers Citigroup Global Markets Inc.
Deutsche Bank Securities Inc.
Merrill Lynch, Pierce, Fenner & Smith
Incorporated
Natixis Securities North America Inc.
Co-Managers Banco Bilbao Vizcaya Argentaria, S.A.
Credit Agricole Securities (USA) Inc.
HSBC Securities (USA) Inc.
Mitsubishi UFJ Securities (USA) Inc.
RBS Securities Inc.
Santander Investment Securities Inc.

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies may be obtained from Citigroup Global Markets Inc., toll free at 1-877-858-5407; Deutsche Bank Securities Inc., toll free at 1-800-503-4611; Merrill Lynch, Pierce, Fenner & Smith Incorporated, toll free at 1-800-294-1322; or Natixis Securities North America Inc. at 1-212-698-3108.

2